Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction (Q45864538)

17 December 2017

title

Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction (English)

1 reference

17 December 2017

main subject

myocardial infarction

1 reference

Kengo Kusano

1

1 reference

17 December 2017

Yoshiaki Tsutsumi

2

1 reference

17 December 2017

Jarrod Dean

3

1 reference

17 December 2017

Mary Gavin

4

1 reference

17 December 2017

Hong Ma

5

1 reference

17 December 2017

Marcy Silver

6

1 reference

17 December 2017

Tina Thorne

7

1 reference

17 December 2017

Yan Zhu

8

1 reference

17 December 2017

Douglas W Losordo

9

1 reference

17 December 2017

Ryuichi Aikawa

10

1 reference

17 December 2017

publication date

15 December 2006

1 reference

17 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

17 December 2017

volume

42

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

390-399

1 reference

17 December 2017

Protective responses in the ischemic myocardium

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Recombinant adeno-associated virus for muscle directed gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Growth hormone prolongs survival in experimental postinfarction heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Recombinant Human Growth Hormone Treatment for Dilated Cardiomyopathy in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorio-allantoic membrane: a novel action of GH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Use of recombinant adeno-associated viral vectors as a tool for labeling bone marrow cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Growth hormone increases regional coronary blood flow and capillary density in aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

The Ki-67 protein: from the known and the unknown

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

CDK inhibitors: positive and negative regulators of G1-phase progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

bcl-2 overexpression promotes myocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2C12 myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.016

10.1016/J.YJMCC.2006.10.016

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017